EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

YouTube ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò


[Thiazide ÀÌ´¢Á¦¿Í ÇǺξÏ] - End of document

[2020-10-25. ÀÌÁØÇà Áú¹®]

Çѱ³¼ö´Ô. ªÀº Áú¹®µå¸³´Ï´Ù. Thiazide ÀÌ´¢Á¦°¡ non-melanoma skin cancer À§ÇèÀ» ³ôÀδٰí Çϴµ¥... ÇöÀç ¾î¶»°Ô ³íÀÇ°¡ µÇ°í ÀÖ´ÂÁö ±Ã±ÝÇÏ´Ù. ªÀº comment ºÎŹÇÕ´Ï´Ù.

[2020-10-26. ÇÑÁÖ¿ë ±³¼ö´Ô ´äº¯]

°á·ÐÀûÀ¸·Î´Â °è¼Ó »ç¿ëÇ϶óÀÔ´Ï´Ù. ´Ù¸¸ ÇǺΠº¸È£¿¡ ½Å°æ¾²±¸¿ä. FDA ÀÔÀåÀÇ ¿ä¾àÀº ´ÙÀ½°ú °°½À´Ï´Ù.

An FDA Sentinel Initiative study found that the increased risk was mostly for squamous cell carcinoma (SCC). In the overall study population, the increased risk for SCC in patients on HCTZ was approximately one additional case per 16,000 patients per year.

In addition, treatment for non-melanoma skin cancer is typically local and successful, with very low rates of death. Meanwhile, the risks of uncontrolled blood pressure can be severe and include life-threatening heart attacks or stroke. Given this information, patients should continue to use HCTZ and take protective skin care measures to reduce their risk of non-melanoma skin cancer, unless directed otherwise from their health care provider.

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng. (since 1999-8-23)